Renal Involvement in Multiple Myeloma
Multiple myeloma (MM) is a plasma cell disorder that represents almost 10% of haematologic malignancies. Renal impairment, one of the most common complications of MM that occurs in 20–50% of patients, can present in a variety of forms and is associated with increased mortality. Myeloma cast nephropa...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2017-08-01
|
Series: | European Medical Journal |
Subjects: | |
Online Access: | https://www.emjreviews.com/oncology/article/editors-pick-renal-involvement-in-multiple-myeloma/ |
id |
doaj-b5da30dc502e4d69aa2012f57c8de631 |
---|---|
record_format |
Article |
spelling |
doaj-b5da30dc502e4d69aa2012f57c8de6312020-11-25T03:58:31ZengEuropean Medical JournalEuropean Medical Journal2397-67642017-08-01234652Renal Involvement in Multiple MyelomaJoana Gameiro0Sofia Jorge1José António Lopes2Service of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Lisboa Norte, Lisbon, PortugalService of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Lisboa Norte, Lisbon, PortugalService of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Lisboa Norte, Lisbon, PortugalMultiple myeloma (MM) is a plasma cell disorder that represents almost 10% of haematologic malignancies. Renal impairment, one of the most common complications of MM that occurs in 20–50% of patients, can present in a variety of forms and is associated with increased mortality. Myeloma cast nephropathy is the most common cause of kidney disease in MM patients, presenting as acute kidney injury in the majority of patients. The recent introduction of new chemotherapy agents, autologous stem cell transplantation, and the development of novel techniques of light chain removal have been associated with improved renal and patient outcomes in MM patients. Nevertheless, dialysis-dependent patients with MM have higher mortality than other dialysis patients and may be considered for kidney transplantation only if sustained remission has been achieved and sustained for at least 3 years, bearing in mind the risk of disease recurrence. The authors review the most frequent renal manifestations associated with MM, namely myeloma cast nephropathy, light-chain amyloidosis, and monoclonal immunoglobulin deposition disease, focussing on the therapeutic options for acute and chronic kidney disease.https://www.emjreviews.com/oncology/article/editors-pick-renal-involvement-in-multiple-myeloma/multiple myeloma (mm)renal impairment (ri)pathogenesistreatment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joana Gameiro Sofia Jorge José António Lopes |
spellingShingle |
Joana Gameiro Sofia Jorge José António Lopes Renal Involvement in Multiple Myeloma European Medical Journal multiple myeloma (mm) renal impairment (ri) pathogenesis treatment |
author_facet |
Joana Gameiro Sofia Jorge José António Lopes |
author_sort |
Joana Gameiro |
title |
Renal Involvement in Multiple Myeloma |
title_short |
Renal Involvement in Multiple Myeloma |
title_full |
Renal Involvement in Multiple Myeloma |
title_fullStr |
Renal Involvement in Multiple Myeloma |
title_full_unstemmed |
Renal Involvement in Multiple Myeloma |
title_sort |
renal involvement in multiple myeloma |
publisher |
European Medical Journal |
series |
European Medical Journal |
issn |
2397-6764 |
publishDate |
2017-08-01 |
description |
Multiple myeloma (MM) is a plasma cell disorder that represents almost 10% of haematologic malignancies. Renal impairment, one of the most common complications of MM that occurs in 20–50% of patients, can present in a variety of forms and is associated with increased mortality. Myeloma cast nephropathy is the most common cause of kidney disease in MM patients, presenting as acute kidney injury in the majority of patients. The recent introduction of new chemotherapy agents, autologous stem cell transplantation, and the development of novel techniques of light chain removal have been associated with improved renal and patient outcomes in MM patients. Nevertheless, dialysis-dependent patients with MM have higher mortality than other dialysis patients and may be considered for kidney transplantation only if sustained remission has been achieved and sustained for at least 3 years, bearing in mind the risk of disease recurrence.
The authors review the most frequent renal manifestations associated with MM, namely myeloma cast nephropathy, light-chain amyloidosis, and monoclonal immunoglobulin deposition disease, focussing on the therapeutic options for acute and chronic kidney disease. |
topic |
multiple myeloma (mm) renal impairment (ri) pathogenesis treatment |
url |
https://www.emjreviews.com/oncology/article/editors-pick-renal-involvement-in-multiple-myeloma/ |
work_keys_str_mv |
AT joanagameiro renalinvolvementinmultiplemyeloma AT sofiajorge renalinvolvementinmultiplemyeloma AT joseantoniolopes renalinvolvementinmultiplemyeloma |
_version_ |
1724456769345814528 |